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Purpose: To ﬁnd out a novel risk factor for peripheral arterial disease (PAD) in the elderly with Type 2
diabetes mellitus (T2DM).
Methods: A cross-sectional study involving 70 out of 146 elderly (60 years) with T2DM whose ankle
ebrachial index (ABI) was measured at the Geriatric Out-patient Clinic, Sanglah Hospital.
Results: Theoverall prevalence of PADwas 30.8% (45 outof 146); inmales, itwas 25.88% (22 out of 85) and in
females, 37.70% (23 out of 61). Only 70 out of 146 subjectswhohad complete datawere further analyzed. By
bivariate correlation test, it was found that age (right ABI: r¼0.396, p< 0.001; left ABI, r¼0.509,
p< 0.001); lying systolic blood pressure (right ABI: r¼0.268, p¼ 0.012; left ABI: r¼0.267, p¼ 0.013);
and concentration of 2-hours post-prandial (2-hpp) plasma glucose (right ABI: r¼0.252, p¼ 0.018) had
inverse correlation with ABI, whereas waist circumference, body mass index, sitting and standing systolic
and diastolic blood pressures, lying diastolic blood pressure, levels of total cholesterol, low-density-lipo-
protein (LDL) cholesterol, high-density-lipoprotein (HDL) cholesterol, triglyceride, fasting plasma glucose,
haemoglobin A1C (A1C), and duration of diabetes, had no correlation with ABI. The ages of subjects who
had PAD were greater than those without PAD (71.5 years vs. 65.2 years, p< 0.001). Homocysteine tended
to be correlated only with left ABI (r¼0.198; p¼ 0.050), but after assessment on sex factor, it
showed that homocysteine had inverse correlation with ABI in males (right ABI: r¼0.371, p< 0.026;
left ABI: r¼0.358,p¼ 0.032).Homocysteine also had apositive correlationwith age (r¼ 0.315, p¼ 0.004).
By multiple regression test, age, LDL cholesterol, and 2-hpp plasma glucose had a role in the PAD event.
Conclusions: Some traditional risk factors (age, lying systolic blood pressure, LDL cholesterol, and 2-hpp
plasma glucose) were related with PAD in the elderly with T2DM. Homocysteine as a novel risk factor
had a correlation with ABI only in the male subjects. Age was the most important risk factor for PAD,
either directly or indirectly through homocysteine (only in males).
Copyright  2010, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
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Aging is a process of gradual decrease of tissue’s ability to
rejuvenate and maintain its normal structure and function; thus,
the tissues cannot resist lesions.1,2 This condition results in the
vulnerability of the elderly of getting ill or acquiring diseases.
Some theories of aging process that currently exist and are
related to the present study are glycosylation process; metabo-
lism causes; free-radical exposure; and, most recently accepted,
telomere shortening.r, Bali 80233, Indonesia.
.T. Kuswardhani).
linical Gerontology & Geriatrics. POne of the diseases that is commonly related to aging is
peripheral arterial disease (PAD), which is known as a marker of
systemic atherosclerosis.3 PAD is an independent risk factor for
cardiovascular death.4 Aging is associated with the increase of PAD
incidence, especially among women. It commonly starts at 40 years
of age and sharply increases after 70 years. The mechanism of PAD
is similar to that of coronary atherosclerosis, which is inﬂuenced by
many risk factors. These factors can be differentiated into tradi-
tional [such as hypercholesterolemia, hypertension, Type 2 dia-
betes mellitus (T2DM), and smoking] and nontraditional (or novel)
risk factors.5e7 Several studies reviewed by Kuswardhani8 show the
prevalence of PAD ranging from 16% to 30%.
Besides traditional risk factors, there are some PAD-related
novel risk factors that are still being studied, such as transformingublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
The characteristics of the 70 study subjects
Variables Range Mean standard
deviation
Age, yr 60e80 67.30 5.59
Waist circumference, cm 35.5e116.5 88.65 14.29
Body mass index 16.44e35.98 24.88 3.71
Lying systolic blood pressure, mmHg 110e194 142.54 19.53
Sitting systolic blood pressure, mmHg 107e194 145.10 18.84
Standing systolic blood pressure, mmHg 100e196 141.66 18.28
Lying diastolic blood pressure, mmHg 54e95 74.57 8.82
Sitting diastolic blood pressure, mmHg 47e106 78.01 9.93
Standing diastolic blood pressure, mmHg 50e100 78.18 10.00
Total cholesterol, mg/dL 108e300 198.00 44.57
Low-density-lipoprotein cholesterol, mg/dL 51e213 127.16 36.29
High-density-lipoprotein cholesterol, mg/dL 25e75 48.68 9.77
Triglyceride, mg/dL 53e521 150.96 90.25
Fasting plasma glucose, mg/dL 50e419 137.53 71.01
2-hpp plasma glucose, mg/dL 109e379 187.01 53.53
A1C, % 5e13.7 7.58 1.94
Duration of diabetes, yr 0.5e37 9.79 8.30
Homocysteine, mmol/L 7.10e24.40 12.41 3.72
Table 2
Correlation between some risk factors for peripheral arterial disease and ABI
Variables Right ABI Left ABI
r p r p
Age 0.396 <0.001* 0.509 <0.001*
Waist circumference 0.106 0.388 0.054 0.660
Body mass index 0.169 0.082 0.158 0.097
Lying systolic blood pressure 0.268 0.012* 0.267 0.013*
Sitting systolic blood pressure 0.131 0.139 0.103 0.199
Standing systolic blood pressure 0.179 0.069 0.193 0.054
Lying diastolic blood pressure 0.064 0.299 0.081 0.252
Sitting diastolic blood pressure 0.144 0.177 0.096 0.215
Standing diastolic blood pressure 0.097 0.213 0.120 0.161
Total cholesterol 0.104 0.195 0.012 0.460
Low-density-lipoprotein cholesterol 0.164 0.087 0.039 0.376
High-density-lipoprotein cholesterol 0.130 0.141 0.052 0.334
Triglyceride 0.050 0.340 0.094 0.218
Fasting plasma glucose 0.100 0.204 0.180 0.068
2-hpp plasma glucose 0.252 0.018* 0.128 0.146
A1C 0.007 0.477 0.010 0.469
Duration of diabetes 0.114 0.179 0.173 0.081
Homocysteine 0.167 0.083 0.198 0.050
*Statistically signiﬁcant, p< 0.05.
ABI¼ ankleebrachial index.
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inducer (Fas ligand), asymmetric dimethylarginine (ADMA), soluble
vascular adhesion molecule 1, high-sensitivity C-reactive protein,
and homocysteine.4,9e17 To date, no data are available regarding
prevalence and risk factors that inﬂuence the mechanism of PAD,
especially among the elderly population with T2DM in Indonesia.
Therefore, a study on the role of some novel or nontraditional risk
factors in the occurrence of PAD in this group was carried out. The
objective of this study was to ﬁnd out the association of a novel risk
factor (homocysteine) and PAD in the elderly with T2DM.
2. Methods
The ﬁrst step of the study was to measure ankleebrachial index
(ABI) to conﬁrm the diagnosis of PAD among 146 elderly patients
(age 60 years) with T2DM, who visited the Geriatric Outpatients
Clinic, Sanglah Hospital, Denpasar, Bali, Indonesia. The prevalence
of PAD in the elderly with T2DM could be calculated from this
population. By using inclusioneexclusion criteria, 70 out of 146
subjects were included for analysis in the cross-sectional study. The
inclusion criteria included age between 60 years and 80 years,
being Indonesian, and willingness to participate in the study with
an informed consent. The exclusion criteria were smoking (last 1
year); acute coronary syndrome or recent heart attack; recent
stroke; acute infection; liver function abnormalities or diseases
(aspartate aminotransferase (AST) and/or alanine aminotransferase
(ALT) 2 normal range, chronic liver disease or liver cirrhosis);
malignancy; acute and chronic kidney diseases with creatinine
serum greater than 3 mg/dL or creatinine clearance test (CCT) <
60 mmol/L (calculated by formula of KockcrofteGault); crisis
hypertension; and technical inability to measure ABI because of
certain conditions, such as extremity amputation.
The variables measured included age; waist circumference; body
mass index (BMI); blood pressure (lying, sitting, and standing posi-
tion); lipid plasma; fasting and 2-hpp plasma glucose; A1C; duration
of diabetes; and homocysteine concentration. To determine the body
height (for BMI calculation), we used the following formula: cor-
rected height¼ 59.01þ (2.08 knee height) for men, and 75.00þ
(1.91 knee height) (0.17 age) for women, in centimeters. Body
weight was measured with automatic weight scale Camry EB6171
(Guangdong, China). Blood pressure was measured with a sphyg-
momanometer in lying, sitting, and standing positions,with intervals
longer than2minutes. ABIwasmeasured using automatic Vasera VS-
1000 (Fukuda, Bunkyo-ku, Tokyo, Japan); homocysteine was
measured using IMX Homocysteine Pack with ﬂuorescence polari-
zation immunoassay method (Abbott Park, Illinois, United States).
Criteria for diabetes were based on those by American Diabetes
Association (2009),18 and PAD was conﬁrmed by ankleebrachial
index (ABI < 0.9). Minimal number of sample requirement by
calculation with cross-sectional formula was 60 subjects.
Statistic tests used in the study were descriptive analysis,
nonparametric one-sample KolmogoroveSmirnov test, bivariate
correlation test (Pearson or Spearman test), and stepwise linear
regression test, with each signiﬁcant value conﬁrmed at p< 0.05.
3. Results
3.1. Proportion of PAD in the elderly with T2DM
One hundred and forty-six patients were included in the study.
Thenumberof samples ingroupwithage60e69yearswasalmost 2.3
times higher than the group with age greater than or equal to 70
years, andmale-to-female ratiowas 58.2:41.8. The overall proportion
of PAD was 30.8% (45 out of 146). The proportion of PAD in the male
subjects was 25.88% (22 out of 85), a little lower than that in femalesubjects, which was 37.70% (23 out of 61), but statistically, they were
not signiﬁcantlydifferent. Itwas found that the subjects aged70years
or older had a signiﬁcant higher proportion of PAD than the subjects
aged 60e69 years (48.89% vs. 20.79%; p¼ 0.001). With this ﬁnding,
it can be concluded that age is an important risk factor for PAD.
3.2. Correlation between ABI and some risk factors for PAD
Seventy out of 146 patients were involved in the cross-sectional
study, for whom all parameters or biomarkers were completely
measured. The characteristics of the 70 subjects are presented in
Table 1. By bivariate correlation test, it was found that age, lying
systolic blood pressure, and concentrations of 2-hpp plasma glucose
had inverse correlationwith ABI (Table 2). It is noted that, the lower
the ABI, the smaller the diameter of peripheral artery. From the
analysis, it was found that age (r¼0.509) had the strongest
correlation, followed by lying systolic blood pressure (r¼0.268),
and 2-hpp plasma glucose (r¼0.252).
This study also showed a tendency of inverse correlation between
homocysteine and ABI, and after being analyzed by sex, it was found
that homocysteine had inverse correlation with ABI in the male
subjects (right ABI: r¼0.371, p< 0.026; left ABI: r¼0.358,
Table 3
Correlation between age and some other risk factors for peripheral arterial disease
Variable Age
r p
Lying systolic blood pressure 0.140 0.125
2-hpp plasma glucose 0.059 0.313
Homocysteine 0.315 0.004*
*Statistically signiﬁcant, p< 0.05.
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between them (right ABI: r¼0.057, p¼ 0.750; and left ABI:
r¼0.071, p¼ 0.689) (Fig. 1).
It is widely known, as also found in this study, that age is an
important risk factor for PAD. Besides being directly associatedwith
PAD, age may likely be indirectly associated with PAD in relation to
other risk factors. To know the association, a correlation test
between age and some other risk factors, both traditional (which
have correlation with ABI) and nontraditional (homocysteine), was
conducted. The result showed that homocysteine was signiﬁcantly
correlated with age (r¼ 0.315, p¼ 0.004) (Table 3).
3.3. The role of risk factors for PAD on ABI
By multiple regressionwith stepwise linear regression test, only
age, low-density-lipoprotein (LDL) cholesterol, and 2-hpp plasma
glucose, out of the all risk factors (age, waist circumference, BMI,
lying systolic blood pressure, sitting systolic bloodpressure, standing
systolic bloodpressure, lying diastolic bloodpressure, sitting diastolic
blood pressure, standing diastolic blood pressure, total cholesterol,
LDL cholesterol, high-density-lipoprotein (HDL) cholesterol, triglyc-
eride, fasting plasma glucose, 2-hpp plasma glucose, A1C, duration of
diabetes, and homocysteine), had an effect on right ABI, and only age
had an effect on left ABI (Tables 4 and 5).
4. Discussion
Prevalence of PAD varies depending on population and geo-
graphical factors. Prevalence of PAD among patients with T2DM is
commonly not accurately conﬁrmed because of the absence of
symptoms and the use of different methods for diagnosis. Using
ABI, the prevalence of PAD in diabetics older than 40 years was
found to be 20%,19 and in those older than 50 years, it was 29%.20
Several other studies found that the prevalence of PAD in dia-
betes varied from 16% to 30%.20,21 Based on surveys in the United
States in 1999e2000, the prevalence of PAD by age and sex showed
that, the older the patients, the greater the prevalence of PAD,
especially increasing sharply after the age of 70 years. No signiﬁcant
difference was found between both sexes. The prevalence of PAD in
the general populationwas lower than that among diabetics.22 Race
also has an inﬂuence on the prevalence of PAD. Data from The
National Health and Nutrition Examination Survey in 1999e2000
showed that the prevalence of PAD was 11.7% among non-Hispanic0,60 0,80 1,00 1,20 1,4
Left ABI
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Fig. 1. Correlation between homocysteine concentration and lefwhites, 19.5% among non-Hispanic blacks, 15.6% among Hispanics,
as adapted from Steffen et al. (2008).23 There are no certain genetic
abnormalities related to PAD.24 In this study, the proportion of PAD
among the elderly with T2DM was similar with those of other
studies. Age, especially greater than 70 years, was the most
important risk factor for PAD. Sex had no relationship with the
proportion of PAD; it can be understood that postmenopausal
women have similar chances of getting cardiovascular diseases as
men. Generally, the proportion of PAD in this study was somewhat
higher than the ﬁndings of other studies, which might be because
of the fact that the samples were a speciﬁc high-risk population,
that is, the elderly with T2DM.
In the study, only lying systolic blood pressure, among other
measurements, had a correlation with ABI. The reason behind this
is not explained yet.
Hyperhomocysteinemia was related with atherosclerosis and
thrombosis.15,16 High homocysteine levels inhibit enzyme dimethy-
larginine dimethylaminohydrolase (DDAH), an enzyme to cleavage
ADMA, and induces ADMA concentration.25 In this study, it was
shown that homocysteine had a relationship with PAD, especially
in men. There is no explanation as yet on why is it only in male
that the association exists. The difference in the prevalence and
degree of PAD between the right and left limbs might reﬂect that
atherosclerosis developed in blood vessels to different degrees. It
can explain why homocysteine is related only with right ABI.
As only a few numbers of risk factors were analyzed in this
study, there are still many other risk factors that are not yet eval-
uated, and this contributed to one of the weaknesses of this study.
Interrelationship among risk factors also induced complexity in
analyzing the role of each risk factor. This problem results in
different ﬁndings concerning the role of each risk factor in different
studies. In this study, we had difﬁculty tracing the family histories
of cardiovascular diseases, and no reliable datawere available about0
I
Female
0,60 0,80 1,00 1,20 1,40
Left ABI
Homocysteine = 13,13 + -1,25 * left ABI 
R-Square = 0,01
t ankleebrachial index by sex. ABI¼ ankleebrachial index.
Table 4
The role of risk factors of PAD on right ABI
Model Unstandardized
coefﬁcients
Standardized
coefﬁcients
t Signiﬁcance
(p)
b Standard
error
b
1. Constant 1.869 0.249 7.492 <0.001
Age 0.013 0.004 0.395 3.436 0.001
2. Constant 2.150 0.269 7.999 <0.001
Age 0.014 0.004 0.447 3.948 <0.001
LDL cholesterol 0.001 0.001 0.267 2.361 0.021
3. Constant 2.243 0.265 8.475 <0.001
Age 0.014 0.004 0.427 3.869 <0.001
LDL cholesterol 0.001 0.001 0.244 2.207 0.031
2-hpp plasma
glucose
0.001 0.000 0.236 2.175 0.033
LDL¼ low-density lipoprotein.
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amount of cigarettes), although we tried to exclude smokers from
the study samples. It is well known that smoking itself is an
important risk factor for PAD and that it can induce an increase in
the homocysteine concentration. No noted history of smoking can
probably explain why the correlation between homocysteine and
ABI exists only in men. Not all risk factors in this study showed
a correlation with ABI, therefore conﬁrming the complexity of the
interrelationship among risk factors and the mechanism of PAD.
Bias in the analysis may also result from incomplete reports about
use of antithrombotic, antidyslipidemic, or oral antidiabetic drugs,
which can inﬂuence the results. This latter limitation may have
resulted in the fact that some risk factors previously expected to
have relationship with ABI or PAD proved to be otherwise.
In our study, no correlationwas found between obesity and long-
term glycemic control (A1C) and ABI. Obesity generally leads to
T2DM, but in the long term, uncontrolled diabetic patients will
induce reduced body weight. Hence, in longstanding diabetic
patients, BMI or obesity cannot be used as a consistent marker for
cardiovascular diseases. Moreover, a part of the elderly patients has
loss of appetite (impairment of taste). It may explain why no corre-
lation between obesity and ABI was found. Reversed association
concerning obesity and cardiovascular disease was shown in an
epidemiological study inNusaCeninganbySuastika et al. (2006),26 in
which the slim group had a greater prevalence of coronary heart
disease as compared with that in those with greater body weight
(normal to obese). Itmay bebecause of the fact that all of the samples
were diabetics; glycemic control was not signiﬁcantly related with
ABI. As already knownand according to theﬁndingofHaffner et al.,27
T2DM was considered an equivalent risk factor for cardiovascular
diseases. Probably, all elderly with T2DM already have some degree
of atherosclerosis. Of course, the diagnosis of PAD by ABI cannot
detect theoccurrenceofmildorearlyatherosclerosis.27Noanalysisof
composite risk factors (glycemic control and duration of diabetes)
and other unstudied risk factors as a cause of failure in proving the
relationship between A1C and ABI is available.
How age induces other risk factors for PAD has not yet been
understood completely. At least, aging itself can cause reducedTable 5
The role of risk factors of PAD on left ABI
Model Unstandardized
coefﬁcients
Standardized
coefﬁcients
t Signiﬁcant
(p)
b Standard
error
b
1. (Constant) 2.149 0.248 8.669 <0.001
Age 0.017 0.004 0.510 4.764 <0.001insulin sensitivity (increased insulin resistance) and beta cell func-
tion.28,29 Insulin resistance is now considered as central to car-
diometabolic syndrome. Both age and T2DM (insulin resistance), as
shown in the subjects in this study,may concomitantly induce higher
concentrations of homocysteine in the population, especially inmen.References
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